First Time Loading...

Bausch Health Companies Inc
TSX:BHC

Watchlist Manager
Bausch Health Companies Inc Logo
Bausch Health Companies Inc
TSX:BHC
Watchlist
Price: 9.65 CAD -0.92% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

26.9B
-2%
Assets
Growth Rates:
1 Year
+6%
3 Years
-11%
5 Years
-17%
7 Years
-36%
10 Years
-4%
28B
-1%
Liabilities
Growth Rates:
1 Year
+7%
3 Years
-8%
5 Years
-6%
7 Years
-27%
10 Years
+22%
-1.1B
-9%
Equity
Growth Rates:
1 Year
-39%
3 Years
-466%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Bausch Health Companies Inc

26.9B
Assets
28B
Liabilities
26.9B
Assets
28B
Liabilities
Current Assets 5.4B
Cash & Short-Term Investments 733m
Receivables 2B
Other Current Assets 2.6B
Non-Current Assets 21.5B
PP&E 1.7B
Intangibles 17.3B
Other Non-Current Assets 2.5B
Current Liabilities 4.4B
Accounts Payable 642m
Accrued Liabilities 3.1B
Other Current Liabilities 614m
Non-Current Liabilities 23.6B
Long-Term Debt 21.5B
Other Non-Current Liabilities 2.1B

Balance Sheet
Bausch Health Companies Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
323
597
542
720
721
3 243
605
582
564
947
Cash Equivalents
323
597
542
720
721
3 243
605
582
564
947
Total Receivables
2 076
2 687
2 517
2 130
1 865
1 839
1 577
1 775
1 790
1 998
Accounts Receivables
2 076
2 687
2 517
2 130
1 865
1 839
1 577
1 775
1 790
1 998
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
889
1 257
1 061
1 048
934
1 107
1 094
993
1 090
1 544
Other Current Assets
844
966
957
848
691
780
2 066
2 257
803
1 107
Total Current Assets
4 132
5 507
5 077
4 746
4 211
6 969
5 342
5 607
4 247
5 596
PP&E Net
1 312
1 442
1 312
1 403
1 353
1 737
1 826
1 845
1 821
1 892
PP&E Gross
1 312
1 442
1 312
1 403
1 353
1 737
1 826
1 845
1 821
1 892
Accumulated Depreciation
978
1 184
1 196
1 430
1 522
1 641
1 781
1 820
1 920
2 083
Intangible Assets
11 278
23 083
18 884
15 211
12 001
10 201
8 445
6 948
5 800
6 456
Goodwill
9 361
18 553
15 794
15 593
13 142
13 126
13 044
12 457
11 547
11 183
Other Long-Term Assets
221
380
2 462
544
1 785
1 830
2 542
2 345
2 271
2 223
Other Assets
9 361
18 553
15 794
15 593
13 142
13 126
13 044
12 457
11 547
11 183
Total Assets
26 305
N/A
48 965
+86%
43 529
-11%
37 497
-14%
32 492
-13%
33 863
+4%
31 199
-8%
29 202
-6%
25 686
-12%
27 350
+6%
Liabilities
Accounts Payable
398
434
324
365
411
503
337
407
521
719
Accrued Liabilities
2 028
3 622
2 649
2 587
3 030
4 315
4 418
4 693
2 958
3 086
Short-Term Debt
6
16
6
905
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
823
1
209
228
1 234
0
0
432
450
Other Current Liabilities
275
418
629
202
167
196
158
98
30
47
Total Current Liabilities
2 708
5 313
3 609
4 268
3 836
6 248
4 913
5 198
3 941
4 302
Long-Term Debt
15 228
30 265
29 845
25 235
24 077
24 661
23 925
22 654
20 334
21 938
Deferred Income Tax
2 221
5 902
5 434
1 180
885
705
528
529
202
163
Minority Interest
122
119
106
95
82
73
70
72
952
940
Other Liabilities
745
1 454
1 383
870
879
1 113
1 228
855
949
1 029
Total Liabilities
21 025
N/A
43 054
+105%
40 377
-6%
31 648
-22%
29 759
-6%
32 800
+10%
30 664
-7%
29 308
-4%
26 378
-10%
28 372
+8%
Equity
Common Stock
8 349
9 897
10 038
10 090
10 121
10 172
10 227
10 317
10 391
10 423
Retained Earnings
2 398
2 750
5 129
2 725
5 664
7 452
8 013
8 961
9 186
9 778
Additional Paid In Capital
244
305
351
380
413
429
454
462
159
214
Other Equity
916
1 542
2 108
1 896
2 137
2 086
2 133
1 924
2 056
1 881
Total Equity
5 279
N/A
5 911
+12%
3 152
-47%
5 849
+86%
2 733
-53%
1 063
-61%
535
-50%
106
N/A
692
-553%
1 022
-48%
Total Liabilities & Equity
26 305
N/A
48 965
+86%
43 529
-11%
37 497
-14%
32 492
-13%
33 863
+4%
31 199
-8%
29 202
-6%
25 686
-12%
27 350
+6%
Shares Outstanding
Common Shares Outstanding
334
343
348
349
350
353
355
359
362
365

See Also

Summary
BHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
BHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BHC stock valuation using valuation multiples.
Wall Street Estimates
BHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.